Ray of LightSam Ginzburg, senior managing director of equity trading at Gruntal, is currently "shorting into strength
Step One: Remove BushelElsewhere, biotech and genomics stocks plummeted for no apparent fundamental reason -- the Amex Biotech Index falling 11.1%, suggesting its recent ascent may indeed have been a case of bubble-itis. "What you're seeing is exactly the same as in other sectors: In the absence of fundamentals, valuations get so overextended there can be -- and I hate to use the word -- a crash
Aaron Task chats on MarketER on Wednesday Nov. 15 at 5 p.m. EST. Join the chat via the top of RealMoney.com's and TSC's homepage.